Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -49.8% | -75.8% | 43.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 53.5% | 67.6% | 62% | 40% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,938.8% | -1,768% | -287.7% | -2,215.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,174.6% | -1,880.7% | -312% | -2,255.1% |
| EPS Diluted | -0.34 | -0.304 | -0.26 | -1.928 |
| % Growth | -11.8% | -17.2% | 86.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |